title: Does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?: Comment on Olson et al.: "Therapeutic Opportunities to Prevent Post-Traumatic Arthritis: Lessons From the Natural History of Arthritis After Articular Fracture".
authors.affiliation: Department of Orthopaedic Surgery, New York University Medical Center, New York, New York, 10003.
authors.forename: Jian-Lu
authors.initials: JL
authors.lastname: Wei
authors.affiliation: Department of Orthopaedic Surgery, New York University Medical Center, New York, New York, 10003.
authors.forename: John
authors.initials: J
authors.lastname: Buza
authors.affiliation: Department of Orthopaedic Surgery, New York University Medical Center, New York, New York, 10003.|Department of Cell Biology, New York University School of Medicine, New York, New York, 10016.
authors.forename: Chuan-Ju
authors.initials: CJ
authors.lastname: Liu
mesh_terms: D000818:Animals; D001168:Arthritis / Q000503:physiopathology* / Q000517:prevention & control*; D057072:Intra-Articular Fractures / Q000150:complications*; D007596:Joints / Q000503:physiopathology*; D008297:Male; D010003:Osteoarthritis / Q000378:metabolism*; D013583:Synovial Membrane / Q000378:metabolism*